OBJECTIVE
The goal of this study was to survey a group of epileptologists in China regarding the treatment of adult epilepsy.
METHODS
A questionnaire on treatment of adult epilepsy was sent to a group of opinion leaders in the field of epilepsy.
RESULTS
For initial monotherapy for idiopathic generalized epilepsy (IGE), valproate was rated as the treatment of choice. In symptomatic localization-related epilepsy (SLRE)/simple partial seizures and SLRE/complex partial seizures, carbamazepine and oxcarbazepine were the respective treatments of choice, whereas in SLRE/secondarily generalized tonic-clonic seizures, carbamazepine, lamotrigine, and oxcarbazepine were treatments of choice. For women who were pregnant or trying to conceive, lamotrigine was the treatment of choice for both IGE and SLRE. In people with epilepsy who were HBsAg positive, whether liver function was normal or not, topiramate and levetiracetam were treatments of choice for IGE. Valproate and levetiracetam were treatments of choice for seizures in the emergency department.
CONCLUSION
A high level of consensus was reached on most treatments of choice and first-line treatments for patients with epilepsy, which were in accordance with published US expert opinion.
[1]
A. Krumholz,et al.
Driving Issues in Epilepsy: Past, Present, and Future
,
2009,
Epilepsy currents.
[2]
F. Talbot.
Treatment of Epilepsy
,
1931
.
[3]
G. Avanzini,et al.
Antiepileptic Drugs as a Cause of Worsening Seizures
,
1998,
Epilepsia.
[4]
T. Tomson,et al.
The pharmacological treatment of epilepsy in adults
,
2011,
The Lancet Neurology.
[5]
Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society
,
2004
.
[6]
Dong Zhou,et al.
Multicenter double‐blind, randomized, placebo‐controlled trial of levetiracetam as add‐on therapy in Chinese patients with refractory partial‐onset seizures
,
2009,
Epilepsia.
[7]
M. Morrell,et al.
Treatment of epilepsy in adults: expert opinion, 2005
,
2005,
Epilepsy & Behavior.
[8]
Josemir W Sander,et al.
The prevalence and treatment gap in epilepsy in China
,
2003,
Neurology.
[9]
P. Kwan,et al.
Early identification of refractory epilepsy.
,
2000,
The New England journal of medicine.